🇺🇸 SRPT — Sarepta Therapeutics, Inc.
Salud MantenerPrecio actual
17,57 USD
Máx. histórico
178,74
2144 días
Split 1:6 del 12/07/2012
Caída desde máximo
-90,17%
Rango 52 semanas
14,68 – 24,68
Variación hoy
-7,48%
Cierre anterior
18,99
Rango de hoy
17,44 – 18,92
Volumen hoy
1.859.162
Peor caída histórica
-98,17%
09/02/2000 → 18/12/2008
Recuperado en 3568 días
Volatilidad anualizada ⓘ
95,43%
- Nombre completo
- Sarepta Therapeutics, Inc.
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 835
- PER ⓘ
- —
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 21,64 USD (puede no estar actualizado)
- Primera cotización
- 04/06/1997
- Precio actualizado
- hace 23 horas
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.
| Fecha | Ratio |
|---|---|
| 12/07/2012 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 25/01/2022 | 65,78 | 69,34 | 64,72 | 68,71 | +2,10% | 7,02% | 2.136.100 |
| 24/01/2022 | 61,64 | 68,00 | 61,48 | 67,30 | +6,03% | 10,58% | 2.422.500 |
| 21/01/2022 | 63,96 | 64,50 | 61,31 | 63,47 | -1,73% | 4,99% | 1.538.200 |
| 20/01/2022 | 64,22 | 66,21 | 63,96 | 64,59 | +2,28% | 3,50% | 1.583.900 |
| 19/01/2022 | 67,31 | 68,00 | 63,01 | 63,15 | -4,49% | 7,41% | 2.281.700 |
| 18/01/2022 | 69,92 | 69,92 | 65,17 | 66,12 | -7,00% | 6,79% | 1.865.400 |
| 14/01/2022 | 72,00 | 72,04 | 68,82 | 71,10 | -1,78% | 4,47% | 1.218.000 |
| 13/01/2022 | 73,32 | 74,68 | 72,24 | 72,39 | -2,11% | 3,33% | 901.400 |
| 12/01/2022 | 75,69 | 76,53 | 72,00 | 73,95 | -3,13% | 5,98% | 1.570.300 |
| 11/01/2022 | 75,87 | 77,84 | 73,75 | 76,34 | +0,25% | 5,39% | 1.374.600 |
| 10/01/2022 | 84,01 | 84,80 | 71,28 | 76,15 | -10,94% | 16,09% | 4.886.800 |
| 07/01/2022 | 86,96 | 92,00 | 84,50 | 85,50 | -1,61% | 8,62% | 2.664.800 |
| 06/01/2022 | 84,28 | 88,07 | 82,92 | 86,90 | +3,34% | 6,11% | 832.900 |
| 05/01/2022 | 88,61 | 90,00 | 83,73 | 84,09 | -5,69% | 7,08% | 946.700 |
| 04/01/2022 | 90,00 | 90,90 | 86,04 | 89,16 | -1,39% | 5,40% | 647.700 |
| 03/01/2022 | 90,10 | 91,74 | 88,62 | 90,42 | +0,41% | 3,46% | 411.000 |
| 31/12/2021 | 90,87 | 92,50 | 89,76 | 90,05 | -0,60% | 3,02% | 311.200 |
| 30/12/2021 | 91,00 | 93,15 | 90,24 | 90,59 | -0,41% | 3,20% | 273.900 |
| 29/12/2021 | 89,73 | 91,17 | 88,60 | 90,96 | +0,94% | 2,86% | 336.600 |
| 28/12/2021 | 90,33 | 93,27 | 89,75 | 90,11 | -1,66% | 3,90% | 361.200 |
| 27/12/2021 | 91,59 | 92,26 | 90,17 | 91,63 | +0,08% | 2,28% | 499.600 |
| 23/12/2021 | 91,06 | 93,50 | 90,70 | 91,56 | +0,76% | 3,07% | 493.400 |
| 22/12/2021 | 90,69 | 91,55 | 88,83 | 90,87 | -0,29% | 3,00% | 565.200 |
| 21/12/2021 | 89,86 | 92,00 | 89,54 | 91,13 | +2,38% | 2,74% | 2.092.000 |
| 20/12/2021 | 87,66 | 90,75 | 86,66 | 89,01 | +1,26% | 4,67% | 1.058.000 |
| 17/12/2021 | 86,44 | 90,50 | 85,54 | 87,90 | +1,20% | 5,74% | 1.576.000 |
| 16/12/2021 | 88,54 | 88,54 | 85,53 | 86,86 | -0,54% | 3,40% | 509.900 |
| 15/12/2021 | 85,68 | 87,45 | 83,73 | 87,33 | +2,02% | 4,34% | 620.600 |
| 14/12/2021 | 82,86 | 87,00 | 82,21 | 85,60 | +1,17% | 5,78% | 647.300 |
| 13/12/2021 | 85,30 | 86,87 | 84,18 | 84,61 | -1,03% | 3,15% | 545.700 |